Can hydrocortisone cause the syndrome of inappropriate antidiuretic hormone secretion (SIADH)?

No, hydrocortisone does not cause SIADH—it treats and corrects it.

Hydrocortisone is actually therapeutic for SIADH-like hyponatremia caused by adrenal insufficiency, not a cause of SIADH itself. The evidence consistently demonstrates that glucocorticoid deficiency (hypocortisolism) leads to inappropriate ADH secretion, and hydrocortisone replacement corrects this pathophysiology 1.

The Pathophysiology: Glucocorticoid Deficiency Causes SIADH

The mechanism is well-established: cortisol deficiency removes the normal tonic suppression of ADH secretion, leading to a clinical picture that mimics SIADH 2, 3. When patients with corticotropic insufficiency develop hyponatremia, it is primarily linked to inappropriate secretion of ADH, which is corrected by hydrocortisone administration 1.

Key Evidence:

• In hypopituitarism with ACTH deficiency, plasma vasopressin levels are inappropriately elevated (1.3-25.8 pmol/L) relative to low plasma osmolality (236-260 mOsm/kg), meeting SIADH criteria 2
• Hydrocortisone therapy resolves this hyponatremia within days by suppressing vasopressin secretion 2, 3
• When patients are restudied on maintenance hydrocortisone, the vasopressin-osmolality relationship normalizes 2

Clinical Context: When Hydrocortisone Prevents Hyponatremia

In neurosurgical patients, particularly those with subarachnoid hemorrhage (SAH), hydrocortisone (1200 mg/day for 10 days) prevents hyponatremia rather than causing it 4:

• In randomized trials, 0% of hydrocortisone-treated SAH patients developed serum sodium <135 mmol/L, compared to 43% of controls 4
• Hydrocortisone prevented excess sodium excretion and maintained target sodium levels throughout treatment 4
• Guidelines recommend hydrocortisone to prevent natriuresis in SAH patients (Class I recommendation) 4

The Diagnostic Pitfall: Misdiagnosing Adrenal Insufficiency as Primary SIADH

This is a critical clinical trap: Patients with hypopituitarism and secondary adrenal insufficiency frequently present with severe hyponatremia that appears identical to SIADH 3, 5. In one series of 185 patients with severe hyponatremia, 28 had unrecognized hypopituitarism, with 12 experiencing recurrent hyponatremia during previous hospitalizations (up to 4 times) before correct diagnosis 3.

Distinguishing Features:

When evaluating apparent SIADH, always exclude adrenal insufficiency 6:

• Basal cortisol in hyponatremic hypopituitarism: 20-439 nmol/L (mean 157 nmol/L)
• Basal cortisol in true SIADH: 274-1732 nmol/L (mean 732 nmol/L) 3
• Look for clinical signs: scanty pubic/axillary hair, pale doughy skin, small testicles in men 3
• SIADH diagnostic criteria explicitly require absence of adrenal insufficiency 6

Glucocorticoid Effects on ADH: The Suppressive Action

Research demonstrates that exogenous glucocorticoids suppress ADH secretion 7:

• After 5 days of prednisolone 30 mg/day, plasma ADH was completely suppressed (<0.4 pg/ml) despite rising plasma osmolality (289→297 mOsm/kg) 7
• Urinary cAMP excretion (reflecting ADH activity) was completely blunted by prednisolone 7
• This suppressive effect is the mechanism by which hydrocortisone corrects hyponatremia in adrenal insufficiency 2

Treatment Algorithm for Hyponatremia with Suspected SIADH

1. First: Rule out adrenal insufficiency before diagnosing primary SIADH 6, 8, 6

   • Measure morning cortisol (if <250 nmol/L with acute illness, strongly suspect adrenal insufficiency) 8
   • Check ACTH if cortisol is low-normal or equivocal
   • Consider trial of hydrocortisone if suspicion remains high 5

2. If adrenal insufficiency confirmed: Hydrocortisone is the treatment, not the cause

   • Acute: 100 mg IV hydrocortisone, then 100 mg/24h continuous infusion 1
   • Hyponatremia typically corrects within days 2, 3

3. If true SIADH (after excluding adrenal insufficiency): Standard SIADH management

   • Fluid restriction, urea, diuretics, demeclocycline, or vaptans 4
   • Do NOT use hydrocortisone as it is not indicated for primary SIADH

Critical Caveat: The Confusing Case Report

One case report describes a patient misdiagnosed with anterior pituitary hypofunction because glucocorticoid therapy was effective, but was ultimately diagnosed with SIADH 9. However, this represents diagnostic confusion rather than evidence that hydrocortisone causes SIADH. The patient's response pattern (improvement with IV hydrocortisone but relapse with oral) and ultimate response to SIADH-specific therapy (fluid restriction, furosemide) suggests either:

• Misdiagnosis throughout (likely true SIADH all along)
• Multifactorial hyponatremia with both components

This single case does not override the consistent mechanistic and clinical evidence that glucocorticoids suppress, not stimulate, ADH secretion.

Bottom Line for Clinical Practice

Hydrocortisone corrects SIADH-like hyponatremia caused by cortisol deficiency—it does not cause SIADH. When evaluating hyponatremia that appears to be SIADH, always measure cortisol and exclude adrenal insufficiency before finalizing the diagnosis 6, 8, 6. If there is any doubt and the patient has compatible clinical features, a trial of hydrocortisone is warranted as this "eminently treatable condition" is frequently overlooked 5.